BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 23762036)

  • 1. Update on the diagnosis and management of refractory coeliac disease.
    Nijeboer P; van Wanrooij RL; Tack GJ; Mulder CJ; Bouma G
    Gastroenterol Res Pract; 2013; 2013():518483. PubMed ID: 23762036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification and management of refractory coeliac disease.
    Rubio-Tapia A; Murray JA
    Gut; 2010 Apr; 59(4):547-57. PubMed ID: 20332526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Jejunal ulcerations - a diagnostic challenge in a patient with coeliac disease].
    Weber M; Schumann M; Felber J; Mireskandari M; Schmidt C; Stallmach A
    Z Gastroenterol; 2015 Nov; 53(11):1261-6. PubMed ID: 26562400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refractory celiac disease: from bench to bedside.
    Malamut G; Meresse B; Cellier C; Cerf-Bensussan N
    Semin Immunopathol; 2012 Jul; 34(4):601-13. PubMed ID: 22810901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring nonresponsive patients who have celiac disease.
    Krauss N; Schuppan D
    Gastrointest Endosc Clin N Am; 2006 Apr; 16(2):317-27. PubMed ID: 16644460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractory coeliac disease.
    Malamut G; Cellier C
    Curr Opin Oncol; 2013 Sep; 25(5):445-51. PubMed ID: 23942290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal T cell receptor gene rearrangements in coeliac disease: implications for diagnosing refractory coeliac disease.
    Hussein S; Gindin T; Lagana SM; Arguelles-Grande C; Krishnareddy S; Alobeid B; Lewis SK; Mansukhani MM; Green PHR; Bhagat G
    J Clin Pathol; 2018 Sep; 71(9):825-831. PubMed ID: 29703761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refractory celiac disease: epidemiology and clinical manifestations.
    Malamut G; Cellier C
    Dig Dis; 2015; 33(2):221-226. PubMed ID: 25925926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refractory Celiac Disease.
    Malamut G; Cellier C
    Gastroenterol Clin North Am; 2019 Mar; 48(1):137-144. PubMed ID: 30711206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognising and Managing Refractory Coeliac Disease: A Tertiary Centre Experience.
    Nasr I; Nasr I; Beyers C; Chang F; Donnelly S; Ciclitira PJ
    Nutrients; 2015 Dec; 7(12):9896-907. PubMed ID: 26633478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refractory coeliac disease.
    Daum S; Cellier C; Mulder CJ
    Best Pract Res Clin Gastroenterol; 2005 Jun; 19(3):413-24. PubMed ID: 15925846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on the management of refractory coeliac disease.
    Al-Toma A; Verbeek WH; Mulder CJ
    J Gastrointestin Liver Dis; 2007 Mar; 16(1):57-63. PubMed ID: 17410290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cells promote expansion and survival of aberrant TCR-negative intraepithelial lymphocyte lines from refractory celiac disease type II patients.
    Schmitz F; Tjon JM; van Bergen J; Koning F
    Mol Immunol; 2014 Mar; 58(1):10-6. PubMed ID: 24252355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential IL-13 production by small intestinal leukocytes in active coeliac disease versus refractory coeliac disease.
    Gross S; van Wanrooij RL; Nijeboer P; Gelderman KA; Cillessen SA; Meijer GA; Mulder CJ; Bouma G; von Blomberg BM; Bontkes HJ
    Mediators Inflamm; 2013; 2013():939047. PubMed ID: 23690672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complications of coeliac disease.
    Malamut G; Cellier C
    Best Pract Res Clin Gastroenterol; 2015 Jun; 29(3):451-8. PubMed ID: 26060109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group.
    Cellier C; Delabesse E; Helmer C; Patey N; Matuchansky C; Jabri B; Macintyre E; Cerf-Bensussan N; Brousse N
    Lancet; 2000 Jul; 356(9225):203-8. PubMed ID: 10963198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant T-lymphocytes in refractory coeliac disease are not strictly confined to a small intestinal intraepithelial localization.
    Verbeek WH; von Blomberg BM; Coupe VM; Daum S; Mulder CJ; Schreurs MW
    Cytometry B Clin Cytom; 2009 Nov; 76(6):367-74. PubMed ID: 19444812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refractory celiac disease.
    Malamut G; Murray JA; Cellier C
    Gastrointest Endosc Clin N Am; 2012 Oct; 22(4):759-72. PubMed ID: 23083992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms and management of refractory coeliac disease.
    van Gils T; Nijeboer P; van Wanrooij RL; Bouma G; Mulder CJ
    Nat Rev Gastroenterol Hepatol; 2015 Oct; 12(10):572-9. PubMed ID: 26347156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The management of complicated celiac disease.
    Al-toma A; Verbeek WH; Mulder CJ
    Dig Dis; 2007; 25(3):230-6. PubMed ID: 17827946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.